Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Medical Plastics Market to Reach USD 48.77 billion by 2031, Growing at a CAGR of 7.0% — MarketsandMarkets™

globenewswire.com
CE Celanese is mentioned as a key participant in the expanding medical plastics market. The article notes its focus on advanced medical-grade polymers, product innovation, and expansion in high-growth medical applications. AI Arkema is listed as a key participant in the medical plastics market, focusing on advanced medical-grade polymers and product innovation. The company is expected to leverage the market's expansion. LZB Lubrizol is identified as a key participant in the medical plastics market, focusing on advanced medical-grade polymers and product innovation. The company is positioned to benefit from the market's growth trajectory. ENS Ensinger is mentioned as a key participant in the medical plastics market, focusing on advanced medical-grade polymers and product innovation. The company's involvement suggests potential growth opportunities. DOW Dow is listed as a key participant in the medical plastics market, focusing on advanced medical-grade polymers and product innovation. The company is expected to benefit from the market's expansion.

Medical Plastics Market to Reach USD 48.77 billion by 2031, Growing at a CAGR of 7.0% — MarketsandMarkets™ Delray Beach, FL, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The global Medical Plastics Market is projected to grow from USD 34.77 billion in 2026 to USD 48.77 billion by 2031, at a CAGR of 7.0% during the forecast period. Growth is driven by rising demand for advanced medical devices, increasing adoption of minimally invasive procedures, growing preference for single-use and disposable medical products, and expanding pharmaceutical and biotechnology industries.

Get PDF Brochure — Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=83738633

Key Market Highlights

Why This Market Matters

Medical plastics enable lightweight, biocompatible, sterilizable, and cost-effective medical products. Their growing use in disposable devices, diagnostic equipment, drug delivery systems, implants, and medical packaging is supporting the shift toward advanced healthcare solutions.

Market Overview

The market is expanding alongside healthcare infrastructure, medical device manufacturing, and demand for minimally invasive procedures. Advanced polymers are increasingly being adopted where high mechanical strength, chemical resistance, thermal stability, and sterilization compatibility are required.

Analyst Perspective

The transition toward high-performance, bio-based, recyclable, and antimicrobial medical plastics is creating new opportunities. At the same time, manufacturers must balance sustainability with stringent requirements for biocompatibility, sterilization, safety, and regulatory compliance.

Speak to Our Analyst — Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=83738633

Segment Analysis

Regional Analysis

North America held the largest market share in 2025, supported by advanced healthcare infrastructure, high healthcare spending, and a strong medical device manufacturing base. Asia Pacific is expected to be the fastest-growing region, driven by expanding healthcare infrastructure, increasing medical device manufacturing, and rising healthcare expenditure.

Key Industry Trends

Competitive Landscape

BASF, Celanese, and SABIC are identified as leading players, supported by strong product portfolios and market presence. Covestro, Syensqo, Evonik, Arkema, Lubrizol, Ensinger, and Dow are also key participants focusing on advanced medical-grade polymers, product innovation, partnerships, and expansion across high-growth medical applications.

Related Reports

Medical Packaging Market

Medical Device Plastics Market